000			01514 a2200469 4500
005			20250518043905.0
264		0	_c20210310
008			202103s 0 0 eng d
022			_a2013-2514
024	7		_a10.1016/j.nefro.2019.03.010 _2doi
040			_aNLM _beng _cNLM
100	1		_aBorrego Utiel, Francisco José
245	0	0	_aUrinary osmolality in patients with polycystic kidney disease: Measured or calculated? _h[electronic resource]
260			_bNefrologia _c
300			_a202-204 p. _bdigital
500			_aPublication Type: Letter
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntidiuretic Hormone Receptor Antagonists _xtherapeutic use
650	0	4	_aCalcium _xurine
650	0	4	_aCreatinine _xurine
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOsmolar Concentration
650	0	4	_aPolycystic Kidney, Autosomal Dominant _xurine
650	0	4	_aPotassium _xurine
650	0	4	_aReceptors, Vasopressin _xdrug effects
650	0	4	_aSodium _xurine
650	0	4	_aTolvaptan _xtherapeutic use
650	0	4	_aUrea _xurine
650	0	4	_aUric Acid _xurine
650	0	4	_aUrine _xchemistry
650	0	4	_aYoung Adult
700	1		_aCamacho Reina, María Victoria
700	1		_aMoriana Domínguez, Clara
700	1		_aMerino García, Enoc
773	0		_tNefrologia _gvol. 40 _gno. 2 _gp. 202-204
856	4	0	_uhttps://doi.org/10.1016/j.nefro.2019.03.010 _zAvailable from publisher's website
999			_c29795933 _d29795933